期刊文献+

舍曲林与氯米帕明治疗强迫症对照研究 被引量:1

下载PDF
导出
摘要 目的比较舍曲林与氯米帕明治疗强迫症的疗效和不良反应。方法以舍曲林和氯米帕明治疗强迫症各30例,疗程8周,应用Yale-Brown强迫症量表(Y-BOCS)、汉密尔顿抑郁量表(HAMD)及汉密尔顿焦虑量表(HAMA)评定疗效。结果舍曲林与氯米帕明治疗后Y-BOCS、HAMD、HAMA分值均显著下降,但舍曲林起效快,副反应少。结论舍曲林治疗强迫症疗效与氯米帕明相仿,不良反应轻而少。
出处 《中国实用医药》 2009年第8期148-149,共2页 China Practical Medicine
  • 相关文献

参考文献3

二级参考文献15

  • 1Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am, 2000, 23:563-586.
  • 2Richelson E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry, 1996, 57 Suppl 11:4-11.
  • 3Gabriels L, Cosyns P, Nuttin B, et al. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopa-thological and neuropsychological outcome in three cases. Acta Psychiatr Scand, 2003, 107:275-282.
  • 4Flament MF, Bisserbe JC. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. J Clin Psychiatry, 1997, 58 Suppl 12:18-22.
  • 5Hollander E, Kaplan A, Allen A, et al. Pharmacotherapy for obsessive-compulsive disorder. Psychiatr Clin North Am, 2000, 23:643-656.
  • 6Gorman JM, Kent JM. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. J Clin Psychiatry, 1999, 60 Suppl 4:33-38.
  • 7Hollander E, Bienstock CA, Koran LM, et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry, 2002, 63 Suppl 6:20-29.
  • 8McDougle CJ. Update on pharmacologic management of OCD: agents and augmentation. J Clin Psychiatry, 1997, 58 Suppl 12:11-17.
  • 9Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry, 1999, 60 Suppl 18:4-15.
  • 10Stein DJ. Advances in the neurobiology of obsessive-compulsive disorder:implications for conceptualizing putative obsessive-compulsive and spectrum disorders. Psychiatr Clin North Am, 2000, 23:545-562.

共引文献91

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部